US Senators Urge PTO’s Vidal To Tackle Pharma Patent Thickets

Thickets Stifle Competition For Generic And Biosimilar Drugs

A bipartisan group of senators has written to the US Patent and Trademark Office, urging it to tackle the impact of patent thickets on the generic and biosimilar drug industries.

Thicket
Patent thickets are known to delay entry of generic competitors to the market. • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin